Parola D et al. |
[Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia]. |
2000 |
Recenti Prog Med |
pmid:10705778
|
Fonquernie L et al. |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment]. |
2000 |
Presse Med |
pmid:10705894
|
Luman W et al. |
One week triple therapy for Helicobacter pylori associated duodenal ulcer disease. |
1999 |
Singapore Med J |
pmid:10709423
|
Coelho LG et al. |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. |
2000 |
Am. J. Gastroenterol. |
pmid:10710099
|
Pilotto A et al. |
In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin. |
2000 |
Am. J. Gastroenterol. |
pmid:10710100
|
Kearney DJ and Brousal A |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. |
2000 |
Dig. Dis. Sci. |
pmid:10711436
|
Lõivukene K et al. |
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. |
2000 |
Scand. J. Infect. Dis. |
pmid:10716079
|
Edlund C et al. |
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. |
2000 |
Scand. J. Infect. Dis. |
pmid:10716083
|
Ani AE et al. |
Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. |
1999 Nov-Dec |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:10717760
|
Tran JQ et al. |
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. |
2000 |
J. Antimicrob. Chemother. |
pmid:10719007
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Numazaki K et al. |
Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10724028
|
Gomollón F et al. |
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain]. |
2000 |
Gastroenterol Hepatol |
pmid:10726384
|
Telenti A and Iseman M |
Drug-resistant tuberculosis: what do we do now? |
2000 |
Drugs |
pmid:10730543
|
Lehmann FS et al. |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735923
|
Miwa H et al. |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735925
|
Spinzi GC et al. |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735926
|
Blackington E |
The gastric demon. An update on Helicobacter pylori infection. |
1999 |
Adv Nurse Pract |
pmid:10745720
|
Paton R et al. |
Susceptibility testing of Haemophilus influenzae to clarithromycin. |
2000 |
J. Antimicrob. Chemother. |
pmid:10747833
|
Shashidhar H et al. |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10749411
|
Joosen EA et al. |
Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects: a prospective intervention study in general practice. |
2000 |
Eur J Gastroenterol Hepatol |
pmid:10750653
|
Woo PC et al. |
Clarithromycin attenuates cyclophosphamide-induced mucositis in mice. |
2000 |
Pharmacol. Res. |
pmid:10753551
|
Bassetti M et al. |
Erythromycin resistance in Streptococcus pyogenes in Italy. |
2000 Mar-Apr |
Emerging Infect. Dis. |
pmid:10756153
|
Shibuya N et al. |
[Effect of clarithromycin on adhesion and infiltration of cancer cells]. |
2000 |
Jpn J Antibiot |
pmid:10756451
|
Majima T et al. |
[Administration of clarithromycin (CAM) to non-small cell lung cancer]. |
2000 |
Jpn J Antibiot |
pmid:10756452
|
Matsunaga Y et al. |
[Effect of clarithromycin on KL-8 formation by epidermal keratocytes]. |
2000 |
Jpn J Antibiot |
pmid:10756455
|
Miyanohara T et al. |
[Effects of macrolides on cultured cells derived from the nose]. |
2000 |
Jpn J Antibiot |
pmid:10756463
|
Sato Y et al. |
[Effect of long-term administration of small dosages of clarithromycin for the treatment of uterine pyometra]. |
2000 |
Jpn J Antibiot |
pmid:10756466
|
Fukushima K et al. |
[Outstanding efficacy of a macrolide in a small dosage for the treatment of refractory skin fistula communicating with the thoracic cavity and accompanying pyothorax]. |
2000 |
Jpn J Antibiot |
pmid:10756469
|
Douthwaite S et al. |
Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. |
2000 |
Mol. Microbiol. |
pmid:10760175
|
Matsiota-Bernard P et al. |
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin. |
2000 |
J. Infect. |
pmid:10762111
|
Benson CA et al. |
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. |
2000 |
J. Infect. Dis. |
pmid:10762562
|
MacArthur RD et al. |
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853. |
2000 |
J. Infect. Dis. |
pmid:10762582
|
Trebesius K et al. |
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. |
2000 |
Gut |
pmid:10764702
|
Schenk BE et al. |
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. |
2000 |
Gut |
pmid:10764703
|
Kadir T et al. |
In vitro effects of clarithromycin on human polymorphonuclear leukocyte functions. |
2000 May-Jun |
Chemotherapy |
pmid:10765036
|
Gasbarrini A et al. |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. |
2000 |
Scand. J. Gastroenterol. |
pmid:10766318
|
Offman E et al. |
Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia. |
2000 |
Chest |
pmid:10767245
|
Bojarski C et al. |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out. |
2000 |
Z Gastroenterol |
pmid:10768243
|
Adamsson I et al. |
Microbial ecology and treatment of Helicobacter pylori infections: review. |
2000 |
J Chemother |
pmid:10768510
|
Singer J et al. |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. |
2000 |
Int J STD AIDS |
pmid:10772083
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Fujimura S et al. |
Clarithromycin-susceptible Helicobacter pylori with mutation in 23S rRNA gene by PCR-RFLP method. |
2000 |
J. Gastroenterol. |
pmid:10777165
|
Abisheganaden JA et al. |
Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial. |
2000 |
Am. J. Med. |
pmid:10781777
|
Kane CL et al. |
Disseminated cutaneous Mycobacterium chelonae infection. |
2000 Mar-Apr |
Cancer Control |
pmid:10783823
|
Shibl AM et al. |
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia. |
2000 |
J Chemother |
pmid:10789552
|
Waites K et al. |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. |
2000 |
J. Clin. Microbiol. |
pmid:10790089
|
Marini RP et al. |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. |
1999 |
Am. J. Vet. Res. |
pmid:10791942
|
Calvet X et al. |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10792124
|
Shimizu T et al. |
Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai. |
2000 |
Br. J. Dermatol. |
pmid:10792258
|
Vernet Vernet M et al. |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians]. |
2000 |
Aten Primaria |
pmid:10795440
|
Boyanova L et al. |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. |
2000 |
J. Med. Microbiol. |
pmid:10798553
|
Boruchoff SE et al. |
The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin. |
2000 |
Clin. Pharmacol. Ther. |
pmid:10801243
|
Azuma T et al. |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10807427
|
Suzuki H et al. |
Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. |
2000 May-Jun |
ORL J. Otorhinolaryngol. Relat. Spec. |
pmid:10810255
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Zuckerman JM |
The newer macrolides: azithromycin and clarithromycin. |
2000 |
Infect. Dis. Clin. North Am. |
pmid:10829265
|
Flockhart DA et al. |
Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. |
2000 |
J Clin Psychopharmacol |
pmid:10831018
|
Spiegel JR et al. |
Prolonged ulcerative laryngitis. |
2000 |
Ear Nose Throat J |
pmid:10832196
|
Miyashita N et al. |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains. |
2000 |
Microbiol. Immunol. |
pmid:10832970
|
Gisbert JP et al. |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. |
2000 |
Eur J Gastroenterol Hepatol |
pmid:10833090
|
Kaushik SP and Vu C |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. |
2000 |
Aust N Z J Med |
pmid:10833116
|
Laine L et al. |
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori. |
2000 |
Gastrointest. Endosc. |
pmid:10840297
|
Romero Gómez M et al. |
[Usefulness of Helicobacter pylori antigen detection in stools in the diagnosis of infection and confirming eradication after treatment]. |
2000 |
Med Clin (Barc) |
pmid:10846675
|
Baños F et al. |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study]. |
2000 |
Med Clin (Barc) |
pmid:10846695
|
Zullo A et al. |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848654
|
Moayyedi P et al. |
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848655
|
Katelaris PH et al. |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848659
|
Ammon S et al. |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848660
|
Leiper K et al. |
Open label trial of oral clarithromycin in active Crohn's disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848665
|
Bhasin DK et al. |
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India. |
2000 |
Helicobacter |
pmid:10849056
|
Nagahara A et al. |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. |
2000 |
Helicobacter |
pmid:10849057
|
Hammerschlag MR and Roblin PM |
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10854812
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Drago L et al. |
Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model. |
2000 Jul-Aug |
Chemotherapy |
pmid:10859433
|
Mikasa K |
[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment]. |
2000 |
Jpn J Antibiot |
pmid:10868303
|
Fraser AG et al. |
Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. |
1999 |
Aust N Z J Med |
pmid:10868529
|
Amayasu H et al. |
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. |
2000 |
Ann. Allergy Asthma Immunol. |
pmid:10875487
|
Maggiolo F et al. |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus. |
2000 |
J Chemother |
pmid:10877512
|
Suzuki K et al. |
[Fibrosing alveolitis following Legionella pneumonia]. |
2000 |
Nihon Kokyuki Gakkai Zasshi |
pmid:10879037
|
Erel F et al. |
Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. |
2000 Mar-Apr |
J Investig Allergol Clin Immunol |
pmid:10879997
|
Delchier JC |
[How to eradicate Helicobacter pylori?]. |
1999 |
Gastroenterol. Clin. Biol. |
pmid:10880913
|
Yanagihara K et al. |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. |
2000 |
J. Antimicrob. Chemother. |
pmid:10882691
|
Saito K et al. |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. |
2000 |
Gastrointest. Endosc. |
pmid:10882958
|
Savarino V et al. |
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886045
|
Wang WH et al. |
High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886046
|
Sung JJ et al. |
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. |
2000 |
Gastroenterology |
pmid:10889149
|
Lamouliatte H et al. |
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. |
2000 |
Gastroenterol. Clin. Biol. |
pmid:10891736
|
Toutous-Trellu L et al. |
Three cases of cutaneous sarcoidosis: search for bacterial agent by the 16S RNA gene analysis and treatment with antibiotics. |
2000 |
Dermatology (Basel) |
pmid:10894973
|
Konno M et al. |
Iron-deficiency anemia associated with Helicobacter pylori gastritis. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10896071
|
Jamal MA et al. |
Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. |
2000 |
Tuber. Lung Dis. |
pmid:10897378
|
Jordan MK et al. |
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898693
|
Kato M et al. |
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10898707
|
Bortolotti M et al. |
Dose-related stimulatory effect of clarithromycin on interdigestive gastroduodenal motility. |
2000 |
Digestion |
pmid:10899723
|
Moayyedi P et al. |
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. |
2000 |
Lancet |
pmid:10905240
|
Miwi H et al. |
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population. |
2000 |
J. Gastroenterol. |
pmid:10905362
|
McCarty J et al. |
Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. |
2000 Jan-Feb |
Adv Ther |
pmid:10915400
|
Lerner FE et al. |
Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers. |
2000 |
Int J Clin Pharmacol Ther |
pmid:10919343
|
Frueh BE et al. |
Mycobacterium szulgai keratitis. |
2000 |
Arch. Ophthalmol. |
pmid:10922211
|